The estimated Net Worth of Raymond V Damadian is at least $2.87 million dollars as of 26 September 2018. Raymond Damadian owns over 900 units of Fonar stock worth over $1,992,207 and over the last 19 years he sold FONR stock worth over $421,814. In addition, he makes $458,895 as Chairman of the Board, Principal Financial Officer et Treasurer at Fonar.
Sign up
Raymond Damadian FONR stock SEC Form 4 insiders trading
Raymond has made over 15 trades of the Fonar stock since 2006, according to the Form 4 filled with the SEC. Most recently he sold 900 units of FONR stock worth $22,212 on 26 September 2018.
The largest trade he's ever made was buying 116,279 units of Fonar stock on 30 May 2006 worth over $50,000. On average, Raymond trades about 22,705 units every 307 days since 2006. As of 26 September 2018 he still owns at least 121,402 units of Fonar stock.
You can see the complete history of Raymond Damadian stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Raymond Damadian biography
Dr. Raymond V. Damadian M.D. serves as Chairman of the Board, Principal Financial Officer, Treasurer of the Company. Dr. Damadian also served as the President and Chief Executive Officer of Fonar. Dr. Damadian was employed by the State University of New York, Downstate Medical Center, New York, as an Associate Professor of Biophysics and Associate Professor of Internal Medicine from 1967 until September 1979. He received an M.D. degree in 1960 from Albert Einstein College of Medicine, New York, and a B.S. degree in mathematics from the University of Wisconsin in 1956. In addition, Dr. Damadian conducted post-graduate work at Harvard University, where he studied extensively in the fields of physics, mathematics and electronics. Dr. Damadian is the author of numerous articles and books on the nuclear magnetic resonance effect in human tissue, which is the theoretical basis for the Fonar MRI scanners. He is a 1988 recipient of the National Medal of Technology. In 1989 he was inducted into the National Inventors Hall of Fame, for his contributions in conceiving and developing the application of magnetic resonance technology to medical applications including whole body scanning and diagnostic imaging. Dr. Damadian is the President, Treasurer and director of Health Management Corporation of America (“HMCA”), a Manager of Imperial Management Services, LLC (“Imperial”) and a Manager of Health Diagnostics Management, LLC (“HDM”) which three entities are subsidiaries of Fonar.
What is the salary of Raymond Damadian?
As the Chairman of the Board, Principal Financial Officer et Treasurer of Fonar, the total compensation of Raymond Damadian at Fonar is $458,895. There are no executives at Fonar getting paid more.
How old is Raymond Damadian?
Raymond Damadian is 83, he's been the Chairman of the Board, Principal Financial Officer et Treasurer of Fonar since 2018. There are 2 older and 6 younger executives at Fonar. The oldest executive at Fonar Corp. is Dr. Raymond V. Damadian M.D., 85, who is the Chairman, Treasurer & Principal Financial Officer.
What's Raymond Damadian's mailing address?
Raymond's mailing address filed with the SEC is 31 Fairbanks Blvd, Woodbury, NY 11797, USA.
Insiders trading at Fonar
Over the last 19 years, insiders at Fonar have traded over $474,389 worth of Fonar stock and bought 335,781 units worth $353,909 . The most active insiders traders include Raymond V Damadian, Robert J Janoff et Timothy Raymond Damadian. On average, Fonar executives and independent directors trade stock every 253 days with the average trade being worth of $248,464. The most recent stock trade was executed by Luciano B Bonanni on 29 September 2022, trading 4,700 units of FONR stock currently worth $66,129.
What does Fonar's logo look like?
Complete history of Raymond Damadian stock trades at Fonar
Fonar executives and stock owners
Fonar executives and other stock owners filed with the SEC include:
-
Dr. Raymond V. Damadian M.D.,
Chairman, Treasurer & Principal Financial Officer -
Raymond Damadian,
Chairman of the Board, Principal Financial Officer, Treasurer -
Luciano Bonanni,
Chief Operating Officer, Executive Vice President -
Timothy R. Damadian,
Pres & CEO -
Timothy Damadian,
President, Chief Executive Officer -
Dr. Raymond V. Damadian,
Chairman, Treasurer & Acting Principal Financial Officer -
Luciano B. Bonanni,
COO & Exec. VP -
Claudette J. V. Chan,
Sec. & Director -
Charles O'Data,
Independent Director -
Ronald Lehman,
Independent Director -
Claudette Chan,
Secretary, Director -
Richard Turk,
Independent Director -
Daniel Culver,
Director of Communications -
Robert J Janoff,
Director